Iterum Therapeutics Plc (ITRM) Misses Q3 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Li Auto Inc. (LI) call put ratio 1.1 calls to 1 put with a focus on September 25 weekly 12.5 puts
• Alibaba (BABA) call put ratio 2.4 calls to 1 put as share price up 3% into President Donald Trump and Chinese President Xi Jinping's summit